Sesen Bio, Inc. (SESN) Hid Information About the Failure of its Clinical Trials for Vicineum On December 21, 2020, Sesen Bio announced it had submitted its Biologics License Application (“BLA”)

ATI Physical Therapy, Inc.  (ATIP) Made Misleading Statements Regarding its Business, Operations, and Prospects     Fortress Value Acquisition Corp. II (“FVAC”) was a special purpose acquisition company that went public

Immunovant, Inc. (IMVT) Misled Shareholders About the Viability of its Drug Candidate IMVT-1401 According to a class action complaint filed on behalf of Immunovant shareholders, Health Sciences Acquisitions Corporation (HSAC)

PureCycle Technologies, Inc. (PCT) Accused of Misstating its Purported Financial Condition and Prospects     According to a class action filed on behalf of purchases of PureCycle, on November 16, 2020,

SelectQuote, Inc. (SLQT) Failed to Disclose Underperformance of its PDP Products     A class action lawsuit was filed on October 7, 2021, on behalf of all persons and entities that

Nano-X Imaging Ltd. (NNOX) Misrepresented Nanox.ARC’s Regulatory and Commercial Prospects A shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Nano-X Imaging

Eargo, Inc. (EAR) Failed to Disclose It Improperly Sought Reimbursements From Third-Party Payors A shareholder filed a class action on behalf of all persons and entities that purchased or otherwise

Corcept Therapeutics Incorporated (CORT) Accused of Illicit Sales Practices In 2012, Corcept Therapeutics Incorporated (CORT) launched its prescription medicine Korlym, which served as Corcept’s only revenue-generating product. Due to the

Chipotle Mexican Grill Inc. (CMG) Violated New York City’s Fair Workweek Law New York City has sued Chipotle for nearly 600,000 violations of the city’s Fair Workweek Law that occurred